Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. D. Tarnoki, D. L. Tarnoki, P. Maurovich-Horvat, A. L. Jermendy, F. Somogyi, B. Merkely, G. Jermendy (Budapest, Hungary). Genetic effects on the diameter of thoracic aorta and pulmonary arteries: A twin study. Eur Respir J 2014; 44: Suppl. 58, 2306

Member's Comments

No comment yet.

Related content which might interest you: Clinical phenotypes in pulmonary emboli identified by cluster analysis Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Immune signatures in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Molecular study of genetic modifiers in patients with pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Outcomes in embolisations of pulmonary arterio-venous malformations Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Single center experience with systematic diagnostic and predictive genetic screening for pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Female pulmonary arterial hypertension is associated with decreased microRNA96 expression Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Isolated hypocapnia: A sign not to be neglected Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Endothelial-to-mesenchymal transition in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Optimization of PH diagnostic process with IVUS during right heart catheterization Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Nebivolol and pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Improving the safety of right heart catheterisation in sickle cell disease Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Pulmonary arterial hypertension – A single-centre experience Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Prognosis factors of recurrent pulmonary thromboembolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Long-term data from the Swiss pulmonary hypertension registry Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Obligatory role of MEK/ERK/RSK90 in the mitogenic responses of human pulmonary artery smooth muscle cells Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 mir-126 contribute to angiogenesis defect in pulmonary arterial hypertension right ventricle failure Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Serum apelin 13 levels in patients with pulmonary embolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 An overview of thrombolytic treatment for pulmonary embolism: A single center experience Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Cardiac MRI derived right ventriculo-arterial coupling in pulmonary hypertension as a predictor of survival Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Do persistent perfusion defects predict late recurrences in pulmonary embolism? Source: International Congress 2014 – Acute pulmonary embolism Year: 2014